Letter to the editor Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscleinvasive Bladder Cancer: A Phase 2 Trial. Eur U
Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial / Roviello, Giandomenico; Antonuzzo, Lorenzo. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - ELETTRONICO. - (2025), pp. 1-1. [10.1016/j.eururo.2025.08.033]
Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial.
Roviello, Giandomenico;Antonuzzo, Lorenzo
2025
Abstract
Letter to the editor Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscleinvasive Bladder Cancer: A Phase 2 Trial. Eur U
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0302283825046950-main.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
231.52 kB
Formato
Adobe PDF
|
231.52 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
